(R)-2-AMINO-3-PHENYLPROPYL CARBAMATE FORMULAS Russian patent published in 2022 - IPC A61K31/27 A61K9/20 A61K47/12 A61K47/34 A61K47/38 A61P25/00 

Abstract RU 2764576 C2

FIELD: pharmaceuticals.

SUBSTANCE: group of inventions relates to the field of pharmaceuticals and medicine, namely, to a pressed tablet with immediate release and an oral dosage form with immediate release for oral delivery of (R)-2-amino-3-phenylpropyl carbamate, containing: 90 to 98 wt.% of (R)-2-amino-3-phenylpropyl carbamate or a pharmaceutically acceptable salt thereof; 1 to 5 wt.% of at least one binding agent; 0.1 to 1.4 wt.% of at least one lubricant; wherein at least 85% of (R)-2-amino-3-phenylpropyl carbamate or a pharmaceutically acceptable salt thereof is released from the tablet within less than 15 minutes after administration of the tablet to a subject; wherein the binding agent is selected from hydroxypropyl cellulose, hydroxypropyl methylcellulose, and povidone, and the lubricant is selected from magnesium stearate, calcium stearate, and sodium stearylfumarate. The group of inventions also relates to methods for treating narcolepsy, cataplexy, excessive daytime drowsiness, medication dependence, sexual dysfunction, fatigue, fibromyalgia, attention deficit/hyperactivity disorder, restless legs syndrome, depression, bipolar disorder, or obesity in a subject in need thereof, or assisting a subject in need thereof in quitting smoking, including administration of said tablet or dosage form to the subject.

EFFECT: group of inventions provides dosage forms with release of at least 85% of the active substance within 15 minutes at different values of pH.

31 cl, 4 dwg, 7 tbl, 2 ex

Similar patents RU2764576C2

Title Year Author Number
PHARMACEUTICAL COMPOSITION OF SLOW RELEASE, CONTAINING APLINDOR AND ITS DERIVATIVES 2004
  • Bendzhamin Ehrik Dzhoehl
  • D'Julin Uehndi Ehnn
  • Lin' Jan'Nin
  • Chzhuan Kaj
RU2376988C2
PHARMACEUTICAL DOSAGE FORMS AND COMPOSITIONS OF COLON ABSORBED PHENYLEPHRINE 2007
  • Montejs Dehjvid
  • O'Mullan Dzhon
  • Reo Dzhozef P.
  • Novak Robert T.
  • Van Dzhiansheng
  • Kabir Mokhammed A.
  • Abutarif Malaz A.
  • Fritts Glenn E.
RU2454225C2
PHARMACEUTICAL COMPOSITIONS FOR PROLONGED RELEASE PHENYLEPHRINE 2007
  • Ulloa Serkhio R.
  • Villakampa Ramos Khose De Khesus Mateo
  • Khuares Vargas Luis Khav'Er
RU2450803C2
PHARMACEUTICAL COMPOSITIONS OF RHEIN OR DIACEREIN 2008
  • Dabre Rakhul
  • Dzhain Girish Kuamr
  • Sandal Roshanlal
  • Tkhakkar Vikrant
RU2484816C2
DOSAGE FORMS OF HISTONE DEACETYLASE INHIBITOR IN COMBINATION WITH BENDAMUSTINE AND THEIR APPLICATION 2011
  • Lauri Devid Dzh.
  • Bagi Dzhozef Dzh.
  • Modi Tarak D.
  • Verner Erik Dzh.
  • Purro Norbert
  • Balasubramanian Sriram
  • Kloos Joanna
  • Depil Stefan
RU2609833C2
SOLID DOSAGE FORMS OF ONDANSETRON WITH PROLONGED RELEASE FOR TREATING SYMPTOMS OF NAUSEA, VOMITING AND DIARRHEA 2015
  • Fatkhi Reza
  • Radaj Gilead
  • Goldberg Gaj
RU2706708C2
DELAYED-RELEASE ORAL DOSAGE FORM OF GABAPENTIN 2005
  • Kandi Kennet K.
  • Sastri Srikonda
  • Leung Mansh'Ju
  • Kadri Baladzhi V.
  • Stehch Pol Eh.
RU2440112C2
COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA 2017
  • Selvaraj, Anand
  • Smith, Peter
RU2769251C2
SOLID COMPOSITIONS BASED ON BETAHISTINE FOR ORAL ADMINISTRATION WITH NON-PULSATING PROLONGED RELEASE 2018
  • Patel Himanshukumar Dasharathlal
  • Dube Vinod Purushottam
  • Naidu Venkataramana
  • Borude Sunil Shantwan
RU2774644C2
COMPOSITIONS AND METHODS FOR TREATING CANCER 2017
  • Kandula Makhesh
RU2770081C2

RU 2 764 576 C2

Authors

Ollfin, Klark Patrik

Uolsh, Edvin Dzherard

Dates

2022-01-18Published

2017-09-06Filed